Article Information
History
- May 14, 2021.
Article Versions
- You are currently viewing Version 1 of this article (May 14, 2021 - 10:13).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rachna T. Shroff1,*,
- Pavani Chalasani1,*,
- Ran Wei2,
- Daniel Pennington1,
- Grace Quirk3,
- Marta V. Schoenle2,3,
- Jennifer L. Uhrlaub2,
- Tyler J. Ripperger2,
- Mladen Jergović2,
- Shelby Dalgai1,
- Alexander Wolf1,
- Hytham Hammad1,
- Amy Carrier1,
- Aaron J. Scott1,
- Janko Nikolich-Žugich2,3,6,
- Michael Worobey3,4,
- Ryan Sprissler3,5,
- Michael Dake7,
- Bonnie J. LaFleur3 and
- Deepta Bhattacharya2,3
- 1Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
- 2Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA
- 3BIO5 Institute, University of Arizona, Tucson, AZ, USA
- 4Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ 85721, USA
- 5University of Arizona Genomics Core and the Arizona Research Labs, University of Arizona Genetics Core, University of Arizona, Tucson, AZ, USA
- 6University of Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ, USA
- 7Office of the Senior Vice-President for Health Sciences, University of Arizona, Tucson, AZ, USA
- ↵*Corresponding authors: Rachna T. Shroff (rshroff{at}arizona.edu), Pavani Chalasani (pchalasani{at}uacc.arizona.edu), Bonnie LaFleur (blafleur{at}arizona.edu) and Deepta Bhattacharya (deeptab{at}arizona.edu).
* Both authors contributed equally to this work
Posted May 14, 2021.
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy
